Senna Natural Relief Tablet
NDC Package 72090-031-10
Package Information
Senna Natural Relief tablets is sennosides are used to treat constipation. This formulation utilizes a tablet delivery system. Marketed by Pioneer Life Sciences, Llc, this product is identified by NDC 72090-031 and is authorized under FDA application 505G(a)(3).
Identification & Billing
- RxCUI: 312935 - sennosides 8.6 MG Oral Tablet
- RxCUI: 312935 - sennosides, USP 8.6 MG Oral Tablet
- RxCUI: 312935 - sennosides A and B 8.6 MG Oral Tablet
Clinical Specifications
- Oral - Administration to or by way of the mouth.
- Oral - Administration to or by way of the mouth.
Regulatory & Marketing
Hierarchy Structure
- 72090 - Pioneer Life Sciences, Llc
- 72090-031 - Senna Natural Relief
- 72090-031-10 - 1000 TABLET in 1 BOTTLE
- 72090-031 - Senna Natural Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72090-031). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72090-031-10 identifies a specific commercial package of 1000 tablet in 1 bottle of Senna Natural Relief, a human over the counter drug labeled by Pioneer Life Sciences, Llc. This tablet is formulated for oral use and contains sennosides as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pioneer Life Sciences, Llc on October 03, 2024. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.
How is this Pioneer Life Sciences, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72090003110. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.